141 related articles for article (PubMed ID: 9935260)
1. Treatment of acute gynecologic infections with trovafloxacin. Trovafloxacin Surgical Group.
Roy S; Koltun W; Chatwani A; Martens MG; Dittrich R; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):67S-73S. PubMed ID: 9935260
[TBL] [Abstract][Full Text] [Related]
2. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
[TBL] [Abstract][Full Text] [Related]
3. Oral trovafloxacin compared with intravenous cefoxitin in the prevention of bacterial infection after elective vaginal or abdominal hysterectomy for nonmalignant disease. Trovafloxacin Surgical Group.
Roy S; Hemsell D; Gordon S; Godwin D; Pearlman M; Luke D
Am J Surg; 1998 Dec; 176(6A Suppl):62S-66S. PubMed ID: 9935259
[TBL] [Abstract][Full Text] [Related]
4. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
O'Doherty B; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
[TBL] [Abstract][Full Text] [Related]
5. Trovafloxacin versus high-dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia.
Trémolières F; de Kock F; Pluck N; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):447-53. PubMed ID: 9758291
[TBL] [Abstract][Full Text] [Related]
6. Treatment of complicated intra-abdominal infections: comparison of the tolerability and safety of intravenous/oral trovafloxacin versus intravenous imipenem/cilastatin switching to oral amoxycillin/clavulanic acid.
Luke DR; Peterson J
Int J Clin Pract; 1999; 53(3):166-73. PubMed ID: 10665126
[TBL] [Abstract][Full Text] [Related]
7. Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis.
Léophonte P; Baldwin RJ; Pluck N
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):434-40. PubMed ID: 9758289
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin.
Williams DJ; Hopkins S
Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261
[TBL] [Abstract][Full Text] [Related]
9. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
10. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group.
Milsom JW; Smith DL; Corman ML; Howerton RA; Yellin AE; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):46S-52S. PubMed ID: 9935257
[TBL] [Abstract][Full Text] [Related]
11. A prospective, double-blind, multicenter study comparing clarithromycin extended-release with trovafloxacin in patients with community-acquired pneumonia.
Sokol WN; Sullivan JG; Acampora MD; Busman TA; Notario GF
Clin Ther; 2002 Apr; 24(4):605-15. PubMed ID: 12017405
[TBL] [Abstract][Full Text] [Related]
12. Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.
Sáez-Llorens X; McCoig C; Feris JM; Vargas SL; Klugman KP; Hussey GD; Frenck RW; Falleiros-Carvalho LH; Arguedas AG; Bradley J; Arrieta AC; Wald ER; Pancorbo S; McCracken GH; Marques SR;
Pediatr Infect Dis J; 2002 Jan; 21(1):14-22. PubMed ID: 11791092
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacy and safety of moxifloxacin and trovafloxacin for the treatment of acute, bacterial maxillary sinusitis in adults.
Klossek JM; Siegert R; Nikolaidis P; Arvis P; Leberre MA;
J Laryngol Otol; 2003 Jan; 117(1):43-51. PubMed ID: 12590855
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of gemifloxacin in acute exacerbations of chronic bronchitis: a randomised, double-blind comparison with trovafloxacin.
Ball P; Wilson R; Mandell L; Brown J; Henkel T;
J Chemother; 2001 Jun; 13(3):288-98. PubMed ID: 11450888
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of trovafloxacin and ofloxacin for single-dose therapy of gonorrhea. Trovafloxacin Gonorrhea Study Group.
Jones RB; Schwebke J; Thorpe EM; Dalu ZA; Leone P; Johnson RB
Am J Med; 1998 Jan; 104(1):28-32. PubMed ID: 9528716
[TBL] [Abstract][Full Text] [Related]
16. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.
van Nispen CH; Hoepelman AI; Rozenberg-Arska M; Verhoef J; Purkins L; Willavize SA
Am J Surg; 1998 Dec; 176(6A Suppl):27S-31S. PubMed ID: 9935254
[TBL] [Abstract][Full Text] [Related]
18. Safety of trovafloxacin in treatment of lower respiratory tract infections.
Williams D; Hopkins S
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):454-8. PubMed ID: 9758292
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
[TBL] [Abstract][Full Text] [Related]
20. In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.
Girard AE; Girard D; Gootz TD; Faiella JA; Cimochowski CR
Antimicrob Agents Chemother; 1995 Oct; 39(10):2210-6. PubMed ID: 8619569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
